rs1567047

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001291303.3(FAT4):​c.10577G>A​(p.Gly3526Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.279 in 1,613,874 control chromosomes in the GnomAD database, including 65,712 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G3526G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.22 ( 4646 hom., cov: 32)
Exomes 𝑓: 0.29 ( 61066 hom. )

Consequence

FAT4
NM_001291303.3 missense

Scores

4
7
7

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 9.80

Publications

35 publications found
Variant links:
Genes affected
FAT4 (HGNC:23109): (FAT atypical cadherin 4) The protein encoded by this gene is a member of the protocadherin family. This gene may play a role in regulating planar cell polarity (PCP). Studies in mice suggest that loss of PCP signaling may cause cystic kidney disease, and mutations in this gene have been associated with Van Maldergem Syndrome 2. Alternatively spliced transcript variants have been noted for this gene. [provided by RefSeq, Mar 2014]
FAT4 Gene-Disease associations (from GenCC):
  • Hennekam lymphangiectasia-lymphedema syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • van Maldergem syndrome 2
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • multiple congenital anomalies/dysmorphic syndrome-intellectual disability
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics
  • Hennekam syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • van Maldergem syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0034423769).
BP6
Variant 4-125451587-G-A is Benign according to our data. Variant chr4-125451587-G-A is described in ClinVar as Benign. ClinVar VariationId is 380813.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.393 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FAT4NM_001291303.3 linkc.10577G>A p.Gly3526Asp missense_variant Exon 10 of 18 ENST00000394329.9 NP_001278232.1 Q6V0I7A0A6Q8JR05X2G5I7B3KU84

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FAT4ENST00000394329.9 linkc.10577G>A p.Gly3526Asp missense_variant Exon 10 of 18 5 NM_001291303.3 ENSP00000377862.4 A0A6Q8JR05
FAT4ENST00000335110.5 linkc.5465G>A p.Gly1822Asp missense_variant Exon 9 of 15 1 ENSP00000335169.5 Q6V0I7-2
FAT4ENST00000674496.2 linkc.5348G>A p.Gly1783Asp missense_variant Exon 9 of 17 ENSP00000501473.2 A0A7P0T1I0

Frequencies

GnomAD3 genomes
AF:
0.224
AC:
34068
AN:
151900
Hom.:
4637
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0641
Gnomad AMI
AF:
0.403
Gnomad AMR
AF:
0.246
Gnomad ASJ
AF:
0.281
Gnomad EAS
AF:
0.407
Gnomad SAS
AF:
0.279
Gnomad FIN
AF:
0.241
Gnomad MID
AF:
0.177
Gnomad NFE
AF:
0.291
Gnomad OTH
AF:
0.248
GnomAD2 exomes
AF:
0.272
AC:
68286
AN:
251236
AF XY:
0.277
show subpopulations
Gnomad AFR exome
AF:
0.0591
Gnomad AMR exome
AF:
0.246
Gnomad ASJ exome
AF:
0.270
Gnomad EAS exome
AF:
0.420
Gnomad FIN exome
AF:
0.242
Gnomad NFE exome
AF:
0.286
Gnomad OTH exome
AF:
0.270
GnomAD4 exome
AF:
0.285
AC:
416655
AN:
1461854
Hom.:
61066
Cov.:
81
AF XY:
0.286
AC XY:
207893
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.0556
AC:
1860
AN:
33480
American (AMR)
AF:
0.244
AC:
10934
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.273
AC:
7134
AN:
26136
East Asian (EAS)
AF:
0.411
AC:
16330
AN:
39700
South Asian (SAS)
AF:
0.291
AC:
25076
AN:
86258
European-Finnish (FIN)
AF:
0.239
AC:
12778
AN:
53420
Middle Eastern (MID)
AF:
0.220
AC:
1271
AN:
5768
European-Non Finnish (NFE)
AF:
0.292
AC:
324640
AN:
1111972
Other (OTH)
AF:
0.275
AC:
16632
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
20780
41561
62341
83122
103902
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10718
21436
32154
42872
53590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.224
AC:
34099
AN:
152020
Hom.:
4646
Cov.:
32
AF XY:
0.223
AC XY:
16603
AN XY:
74296
show subpopulations
African (AFR)
AF:
0.0640
AC:
2657
AN:
41522
American (AMR)
AF:
0.247
AC:
3770
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.281
AC:
973
AN:
3468
East Asian (EAS)
AF:
0.407
AC:
2092
AN:
5134
South Asian (SAS)
AF:
0.279
AC:
1339
AN:
4800
European-Finnish (FIN)
AF:
0.241
AC:
2543
AN:
10570
Middle Eastern (MID)
AF:
0.177
AC:
52
AN:
294
European-Non Finnish (NFE)
AF:
0.291
AC:
19774
AN:
67960
Other (OTH)
AF:
0.252
AC:
532
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1262
2523
3785
5046
6308
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
362
724
1086
1448
1810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.273
Hom.:
27893
Bravo
AF:
0.220
TwinsUK
AF:
0.297
AC:
1101
ALSPAC
AF:
0.302
AC:
1163
ESP6500AA
AF:
0.0663
AC:
292
ESP6500EA
AF:
0.300
AC:
2578
ExAC
AF:
0.267
AC:
32446
Asia WGS
AF:
0.314
AC:
1092
AN:
3478
EpiCase
AF:
0.291
EpiControl
AF:
0.290

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Jan 27, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 46% of patients studied by a panel of primary immunodeficiencies. Number of patients: 44. Only high quality variants are reported. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 27% of total chromosomes in ExAC -

Van Maldergem syndrome 2 Benign:2
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hennekam lymphangiectasia-lymphedema syndrome 2 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.23
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.39
T;.
Eigen
Pathogenic
0.89
Eigen_PC
Pathogenic
0.86
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.91
D;D
MetaRNN
Benign
0.0034
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.8
M;.
PhyloP100
9.8
PrimateAI
Uncertain
0.67
T
PROVEAN
Pathogenic
-4.6
D;D
REVEL
Uncertain
0.50
Sift
Uncertain
0.013
D;D
Sift4G
Uncertain
0.0050
D;D
Polyphen
1.0
D;D
Vest4
0.88
MPC
0.74
ClinPred
0.026
T
GERP RS
5.8
Varity_R
0.41
gMVP
0.72
Mutation Taster
=28/72
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1567047; hg19: chr4-126372742; COSMIC: COSV58676353; COSMIC: COSV58676353; API